Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
CGGR vs TCHP: A Closer Look at Diversified Growth Versus Concentrated Tech Exposure

CGGR vs TCHP: A Closer Look at Diversified Growth Versus Concentrated Tech Exposure

Key Takeaways

  • CGGR and TCHP are both actively managed large-cap growth ETFs, but they pursue very different risk profiles: CGGR favors broad, diversified growth, while TCHP makes a concentrated, high-conviction bet on mega-cap technology.
  • Cost gap: CGGR charges a 0.39% expense ratio versus TCHP's 0.57%, giving CGGR a meaningful structural cost advantage over the long term.
  • Concentration risk: TCHP's top 10 holdings represent roughly 55%–67% of assets, with NVDA alone near 15%, while CGGR's top 10 typically sit near 40% and no single name dominates.
  • Sector exposure: TCHP allocates close to half its portfolio to information technology, whereas CGGR spreads exposure more evenly across technology, communication services, healthcare, and consumer discretionary.
  • Transparency: CGGR is a fully transparent active ETF, while TCHP is a semi-transparent (non-transparent) structure that discloses full holdings only quarterly.
  • Tickeron AI Verdict: CGGR — its lower cost, broader diversification, and more balanced sector positioning make it the structurally stronger choice in this ETF comparison.

Introduction

Investors looking for large-cap growth exposure often come across two actively managed ETFs that appear to target similar results: CGGR and TCHP. Both aim for long-term capital growth by focusing on U.S. companies with strong earnings potential, yet their approaches diverge in meaningful ways. CGGR, managed by Capital Group, uses a multi-manager setup for broader diversification. TCHP, from T. Rowe Price, takes a more concentrated stance on a select group of blue-chip growth names. Examining the differences helps clarify how costs, holdings, and sector weights influence performance and positioning.

Capital Group Growth ETF (CGGR) Overview

CGGR launched in February 2022 as an actively managed ETF seeking capital growth across U.S. companies of varying sizes. Multiple portfolio managers each handle a portion of the fund, which helps spread stock-selection decisions. The portfolio typically includes around 100 holdings, with the top 10 making up about 40% of assets.

Leading positions feature META, NVDA, MSFT, AVGO, and TSLA, along with V, GOOGL, AMZN, and LLY. Information technology leads at roughly 40%, followed by communication services, healthcare, and consumer discretionary in the low-to-mid teens. The fund also maintains notable exposure to mid- and small-cap names, often over 20%, which distinguishes it from many peers. Its expense ratio stands at 0.39%.

T. Rowe Price Blue Chip Growth ETF (TCHP) Overview

TCHP began trading in August 2020 as an actively managed, semi-transparent ETF. It commits at least 80% of assets to blue-chip growth companies with strong market positions and earnings potential. Classified as non-diversified, the fund holds a tighter lineup of roughly 55–75 names.

Top holdings center on NVDA (historically near 15%–17%), MSFT, AAPL, AMZN, GOOG, AVGO, and META, with the top 10 often exceeding 55% of assets. Information technology makes up close to half the portfolio, with communication services and consumer discretionary adding about a third more. This focused, tech-weighted approach leads to higher beta and greater concentration risk. The expense ratio is 0.57%.

Industry and Thematic Backdrop

Both ETFs align with the artificial-intelligence and cloud-computing trends that have shaped markets recently. Strong demand for semiconductors and data-center infrastructure has supported earnings at shared holdings such as NVDA, MSFT, and AVGO. At the same time, heavy exposure to these areas leaves the funds sensitive to interest-rate shifts, valuation changes, and any move away from mega-cap growth. Additional factors like regulatory pressures on large tech platforms and semiconductor supply issues also affect positioning.

Performance and Positioning Comparison

Over recent cycles, TCHP has tended to magnify both gains and losses in the large-cap growth space due to its heavier technology weighting and concentration in names like NVDA. This can deliver stronger results when mega-cap tech leads but larger declines when sentiment changes. CGGR, on the other hand, has shown more measured volatility thanks to its wider sector spread and mid-cap exposure. Its lighter weighting in the biggest index names and allocations to healthcare, financials, and industrials offer some buffer during rotations. Choosing between them comes down to balancing concentrated momentum with diversified stability. I also checked sector weights using Tickeron’s AI Screener to compare the two side by side.

Using Tickeron’s AI Screener for ETF Research

In my own analysis process, I regularly turn to Tickeron’s AI Screener to quickly filter ETFs by factors like sector allocation, expense ratios, and concentration levels. It surfaces relevant comparisons efficiently and helps confirm structural differences without manual number crunching. This tool has become a standard part of how I evaluate options like CGGR and TCHP before forming a view.

Tickeron AI Verdict

From what I see in the structural details, Tickeron’s AI points toward CGGR as the stronger choice here. The edge comes from its lower expense ratio of 0.39% compared with 0.57%, wider diversification across about 100 holdings versus a much tighter portfolio, and reduced exposure to any single stock or sector. While TCHP delivers more direct, higher-beta access to mega-cap technology momentum, CGGR’s balanced allocations, multi-manager approach, and full transparency offer a steadier base across different market conditions. Outcomes are never certain, and investors should consider their own comfort with volatility and concentration levels.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TCHP, CGGR

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


TCHP in downward trend: price dove below 50-day moving average on October 16, 2026

TCHP moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 35 of 40 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TCHP as a result. In 55 of 73 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for TCHP turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 39 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

The 10-day moving average for TCHP crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCHP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for TCHP entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TCHP's RSI Indicator exited the oversold zone, 30 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +3.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCHP advanced for three days, in 294 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

TCHP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), NVIDIA Corp (NASDAQ:NVDA), Microsoft Corp (NASDAQ:MSFT), Alphabet (NASDAQ:GOOGL), Alphabet (NASDAQ:GOOG), Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), Broadcom Inc. (NASDAQ:AVGO), Eli Lilly & Co (NYSE:LLY).

Industry description

The investment seeks to provide long-term capital growth; income is a secondary objective. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of blue-chip companies with growth characteristics. Blue chip growth companies are firms that, in the investment adviser's view, are well established in their industries and have the potential for above-average earnings growth. It focuses on companies with leading market positions, seasoned management, and strong financial fundamentals. The fund is non-diversified.

Market Cap

The average market capitalization across the T. Rowe Price Blue Chip Growth ETF (TCHP) ETF is 670.3B. The market cap for tickers in the group ranges from 52.96B to 5T. AAPL holds the highest valuation in this group at 5T. The lowest valued company is CVNA at 52.96B.

High and low price notable news

The average weekly price growth across all stocks in the T. Rowe Price Blue Chip Growth ETF (TCHP) ETF was -3%. For the same ETF, the average monthly price growth was -9%, and the average quarterly price growth was -11%. AVGO experienced the highest price growth at 3%, while NVDA experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the T. Rowe Price Blue Chip Growth ETF (TCHP) ETF was 7%. For the same stocks of the ETF, the average monthly volume growth was 25% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 78
P/E Growth Rating: 58
Price Growth Rating: 45
SMR Rating: 40
Profit Risk Rating: 56
Seasonality Score: 11 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.